Mitomycin C reduces corneal light scattering after excimer keratectomy

Cornea. 2001 Jan;20(1):45-9. doi: 10.1097/00003226-200101000-00009.

Abstract

Purpose: To evaluate the effect of intraoperative mitomycin C (MMC) on corneal light scattering after excimer laser keratectomy.

Methods: Phototherapeutic keratectomy (PTK) was performed in 24 rabbit eyes. After 40-microm epithelial ablation, animals were divided into three groups. In group 1, filter paper discs soaked with MMC (group 1A, 0.5 mg/mL; group 1B, 0.25 mg/ml) were applied for 1 minute. In group 2, annular filter papers soaked with MMC (group 2A, 0.5 mg/mL; group 2B, 0.25 mg/mL) were applied for 1 minute. Controls received vehicle only (group 3). Six-millimeter diameter 100-microm deep PTK was performed. Corneal light scattering was measured weekly from 1 to 6 weeks, at 10 weeks, and at 8 and 13 months using a scatterometer. A corneal light scattering index (SI) ranging from 0 to 10 was calculated; SI of 1 represents normal scattering.

Results: A statistically significant decrease in mean SI was noted in group 2A (annular MMC 0.5 mg/mL; p<0.05) as compared with the control group at 2 weeks. At 10 weeks, SI approached baseline levels in group 2 and the control group but showed significant increase in group 1 (MMC disc; p < 0.05). At 8 and 13 months, SI showed no statistical differences between groups.

Conclusions: Controlled application of 0.5 mg/mL MMC in the corneal midperiphery transiently reduces corneal light scattering after excimer keratectomy in this rabbit model.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkylating Agents / administration & dosage*
  • Animals
  • Cicatrix / etiology
  • Cicatrix / pathology
  • Cicatrix / prevention & control*
  • Cornea / drug effects*
  • Cornea / pathology
  • Cornea / surgery
  • Corneal Diseases / etiology
  • Corneal Diseases / pathology
  • Corneal Diseases / prevention & control*
  • Drug Evaluation, Preclinical
  • Intraoperative Period
  • Lasers, Excimer
  • Light
  • Mitomycin / administration & dosage*
  • Ophthalmic Solutions
  • Photorefractive Keratectomy / adverse effects*
  • Rabbits
  • Scattering, Radiation
  • Wound Healing / drug effects

Substances

  • Alkylating Agents
  • Ophthalmic Solutions
  • Mitomycin